Kenneth B. Adler
Corporate Officer/Principal en North Carolina State University .
Perfil
Kenneth B.
Adler is the founder of BioMarck Pharmaceuticals Ltd.
which was founded in 2002.
He held the title of Chief Scientist.
Currently, Dr. Adler is a Professor at North Carolina State University.
Dr. Adler received a doctorate degree from the University of Vermont.
Cargos activos de Kenneth B. Adler
| Empresas | Cargo | Inicio |
|---|---|---|
| North Carolina State University | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Kenneth B. Adler.
| Empresas | Cargo | Fin |
|---|---|---|
BioMarck Pharmaceuticals Ltd.
 BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Fundador | - |
Formación de Kenneth B. Adler.
| University of Vermont | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Kenneth B. Adler
